The sodium/iodide symporter (NIS): Characterization, regulation, and medical significance

Endocrine Reviews

Volumn 24, Issue 1, 2003, Pages 48-77

  Dohán, Orsolya ^a   De La Vieja, Antonio ^a   Paroder, Viktoriya ^a   Riedel, Claudia ^a   Artani, Mona ^a   Reed, Mia ^a   Ginter, Christopher S ^a   Carrasco, Nancy ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GLYCOPROTEIN; SODIUM IODIDE SYMPORTER;

ACTIVE TRANSPORT; BASOLATERAL MEMBRANE; BIOGENESIS; BREAST CANCER; CANCER DIAGNOSIS; CELL MEMBRANE; COLLOID; DESTRUCTION; ELECTROPHYSIOLOGY; GENOME; HUMAN; MEDICAL RESEARCH; METASTASIS; MILK; NONHUMAN; NURSING; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SALIVARY GLAND; SAMPLING; SIGNAL TRANSDUCTION; STOMACH MUCOSA; THYROID CANCER; THYROID FOLLICLE CELL; THYROID HORMONE SYNTHESIS; TRANSCRIPTION REGULATION;

AUTOIMMUNE DISEASES; BIOLOGICAL TRANSPORT; BREAST NEOPLASMS; GENE EXPRESSION REGULATION; HUMANS; IODIDES; MUTATION; ORGAN SPECIFICITY; SIGNAL TRANSDUCTION; SYMPORTERS; THYROID DISEASES; THYROID NEOPLASMS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 0037326161     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.2001-0029     Document Type: Review

References (245)

1. Carrasco N 1993 Iodide transport in the thyroid gland. Biochim Biophys Acta 1154:65-82
2. Mazzaferri EL 2000 Carcinoma of the follicular epithelium. In: Braverman LE, Utiger R, eds. The thyroid: a fundamental and clinical text. 8th ed. Philadelphia: Lippincott; 904-930
3. Dai G, Levy O, Carrasco N 1996 Cloning and characterization of the thyroid iodide transporter. Nature 379:458-460
4. Dai G, Levy O, Amzel LM, Carrasco N 1996 The mediator of thyroidal iodide accumulation: the sodium/iodide symporter. In: Konings WN, Kaback HR, Lolkema JS, eds. Handbook of biological physics. Transport processes in eukaryotic and prokaryotic organisms. Amsterdam: Elsevier; 343-367
5. Levy O, Carrasco N 1997 Structure and function of the thyroid iodide transporter and its implications for thyroid disease. Curr Opin Endocrinol Diabetes 4:364-370
6. - symporter (NIS), recent advances. J Bioenerg Biomembr 30:195-206
7. Schmutzler C, Köhrle J 1998 Implications of the molecular characterizations on the sodium-iodide symporter (NIS). Exp Clin Endocrinol Diabetes 106:S1-S10
8. Dohan O, De la Vieja A, Carrasco N 2000 Molecular study of the sodium-iodide symporter (NIS): a new field in thyroidology. Trends Endocrinol Metab 11:99-105
9. De la Vieja A, Dohan O, Levy O, Carrasco N 2000 Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology. Physiol Rev 80:1083-1105
10. Filetti S, Bidart JM, Arturi F, Caillou B, Russo D, Schlumberger M 1999 Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism. Eur J Endocrinol 141:443-457
11. Spitzweg C, Heufelder AE 1998 The sodium iodide symporter: its emerging relevance to clinical thyroidology Eur J Endocrinol 138:374-375
12. Riedel C, Dohan O, De la Vieja A, Ginter CS, Carrasco N 2001 Journey of the iodide transporter NIS: from its molecular identification to its clinical role in cancer. Trends Biochem Sci 26:490-496
13. Jhiang SM 2000 Regulation of sodium/iodide symporter. Rev Endocr Metab Disord 1:205-215
14. Tazebay UH, Wapnir IL, Levy O, Dohán O, Zuckier LS, Zhao QH, Deng HF, Amenta PS, Fineberg S, Pestell RG, Carrasco N 2000 The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat Med 6:871-878
15. Mazzaferri EL, Kloos RT 2001 Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86:1447-1463
16. Baumann E 1896 Uber den Jodgehalt der Schilddrüsen von Menchen und tieren. Hoppe Seylers Z Physiol Chem 22:1-17
17. Halmi NS, Suelke RG 1956 Problems of thyroidal self-regulation. Metabolism 5:646-651
18. Halmi NS 1961 Thyroidal iodide transport. Vitam Horm 19:133-163
19. WolfF J 1964 Transport of iodide and other anions in the thyroid gland. Physiol Rev 44:45-90
20. Scott DA, Wang R, Kreman TM, Sheffield VC, Karniski LP 1999 The Pendred syndrome gene encodes a chloride-iodide transport protein. Nat Genet 21:40-443
21. Rodriguez AM, Perron Lacroix L, Caillou B, Leblanc G, Schlumberger M, Bidart JM, Pourcher T 2002 Identification and characterization of a putative human iodide transporter located at the apical membrane of thyrocytes. J Clin Endocrinol Metab 87:3500-3503
22. Progress towards the elimination of iodine deficiency disorders (IDD). Document WHO/NHD/99.4 (http://www.who.int/nut/publications.htm#idd)
23. Assessment of iodine deficiency disorders and monitoring their elimination. Document WHO/NHD/01.1 (http://www.who.int/nut/publications.htm#idd)
24. Fu D, Libson A, Miercke LJ, Weitzman C, Nollert P, Krucinski J, Stroud RM 2000 Structure of a glycerol-conducting channel and the basis for its selectivity. Science 290:481-486
25. + conduction and selectivity. Science 280:69-77
26. Deisenhofer J, Epp O, Miki K, Huber R, Michel H 1984 X-ray structure analysis of a membrane protein complex. Electron density map at 3 A resolution and a model of the chromophores of the photosynthetic reaction center from Rhodopseudomonas viridis. J Mol Biol 5:385-398
27. Sui H, Han BG, Lee JK, Walian P, Jap BK 2001 Structural basis of water-specific transport through the AQP1 water channel. Nature 414:872-878
28. Locher KP, Lee AT, Rees DC 2002 The E. coli BtuCD structure: a framework for ABC transporter architecture and mechanism. Science 296:1091-1098
29. - symporter with an anti-COOH terminus antibody. Proc Natl Acad Sci USA 94:5568-5573
30. Paire A, Bernier-Valentin F, Selmi-Ruby S, Rousset B 1997 Characterization of the rat thyroid iodide transporter using anti-peptide antibodies. J Biol Chem 272:18245-18249
31. - symporter (NIS). Implications for its secondary structure model. J Biol Chem 273:22657-22663
32. De la Vieja A, Ginter CS, Carrasco N, Topology of the sodium/iodide symporter. Program of the 12th International Thyroid Congress, Kyoto, Japan, 2000, p 162 (Abstract P-225)
33. - symporter. Mechanism, stoichiometry, and specificity. J Biol Chem 272:27230-27238
34. Smanik PA, Liu Q, Furminger TL, Ryu K, Xing S, Mazzaferri EL, Jhiang SM 1996 Cloning of the human sodium iodide symporter. Biochem Biophys Res Commun 226:339-345
35. Smanik PA, Ryu KY, Theil KS, Mazzaferri EL, Jhiang SM 1997 Expression, exon-intron organization, and chromosome mapping of the human sodium iodide symporter. Endocrinology 138:3555-3558
36. Ruby S, Watrin C, Rousset B, Molecular cloning and functional analyses of the pig sodium iodide symporter: evidence for three forms generated by alternative splicing. Program of the 12th International Thyroid Congress, Kyoto, Japan, 2000, p 107 (Abstract O-006)
37. Perron B, Rodriguez AM, Leblanc G, Pourcher T 2001 Cloning of the mouse sodium iodide symporter and its expression in the mammary gland and other tissues. J Endocrinol 170:185-196
38. Reizer J, Reizer A, Saier Jr MH 1994 A functional superfamily of sodium/solute symporters. Biochim Biophys Acta 1197:133-166
39. +/glucose cotransporter SGLT1. J Biol Chem 271:1925-1934
40. +/proline transporter of Escherichia coli. J Biol Chem 273:26400-26407
41. +/proline transporter of Escherichia coli. Biochemistry 39:4831-4837
42. Rost B, Sander C 1994 Combining evolutionary information and neural networks to predict protein secondary structure. Proteins 19:55-72
43. Turk E, Wright EM 1997 Membrane topology motifs in the SGLT cotransporter family. J Membr Biol 159:1-20
44. Shafqat S, Velaz-Faircloth M, Henzi VA, Whitney KD, Yang-Feng TL, Seldin MF, Fremeau Jr RT 1995 Human brain-specific L-proline transporter: molecular cloning, functional expression, and chromosomal localization of the gene in human and mouse genomes. Mol Pharmacol 48:219-229
45. +dependent multivitamin transporter. Cloning, functional expression, gene structure, and chromosomal localization. J Biol Chem 274:14875-1483
46. Prasad PD, Wang H, Kekuda R, Fujita T, Fei YJ, Devoe LD, Leibach FH, Ganapathy V 1998 Cloning and functional expression of a cDNA encoding a mammalian sodium-dependent vitamin transporter mediating the uptake of pantothenate, biotin, and lipoate. J Biol Chem 273:7501-7506
47. Okuda T, Haga T 2000 Functional characterization of the human high-affinity choline transporter. FEBS Lett 484:92-97
48. Okuda T, Haga T, Kanai Y, Endou H, Ishihara T, Katsura I 2000 Identification and characterization of the high-affinity choline transporter. Nat Neurosci 3:120-125
49. +/solute symport in prokaryotes. Biochim Biophys Acta 1505:131-143
50. - symporter (NIS) function from analysis of a mutation that causes human congenital hypothyroidism. FEBS Lett 429:36-40
51. - symporter. Nat Genet 16124-125
52. De la Vieja A, Ginter C, Carrasco N, Several hydroxyl-containing amino acid residues in transmembrane segment IX are important for sodium/iodide symporter activity. 12th International Thyroid Congress, Kyoto, Japan, 2000, p 162 (Abstract P-226)
53. - symporter activity requires a small and uncharged amino acid residue at position 395. Mol Endocrinol 16:1893-1902
54. Barker HM 1936 The blood cyanates in the treatment of hypertension. JAMA 106:762-767
55. Soldin OP, Braverman LE, Lamm SH 2001 Perchlorate clinical pharmacology and human health: a review. Ther Drug Monit 23:316-331
56. Martino E, Bartalena L, Bogazzi F, Braverman LE 2001 The effects of amiodarone on the thyroid. Endocr Rev 22:240-254
57. Wolff J 1998 Perchlorate and the thyroid gland. Pharmacol Rev 50:89-105
58. Lawrence JE, Lamm SH, Pino S, Richman K, Braverman LE 2000 The effect of short-term low-dose perchlorate on various aspects of thyroid function. Thyroid 10:659-663
59. Hilditch TE, Horton PW, McCruden DC, Young RE, Alexander WD 1982 Defects in intrathyroid binding of iodine and the perchlorate discharge test. Acta Endocrinol (Copenh) 100:237-244
60. McCruden DC, Hilditch TE, Connell JM, McLellan AR, Robertson J, Alexander WD 1987 Duration of antithyroid action of methimazole estimated with an intravenous perchlorate discharge test. Clin Endocrinol (Oxf) 26:33-39
61. McDougall R, Cavalieri RR 2000 In vivo radionuclide tests and imaging. In: Braverman LE, Utiger R, eds. The thyroid: a fundamental and clinical text. 8th ed. Philadelphia: Lippincott-Raven; 355-375
62. -, studied in FRTL-5 cells. Biochim Biophys Acta 1414:231-237
63. - symporter. Biochem Biophys Res Commun 231:731-734
64. Weiss SJ, Philip NJ, Ambesi-Impiombato FS, Grollman EF 1984 Thyrotropin-stimulated iodide transport mediated by adenosine 3′5′-monophosphate and dependent on protein synthesis. Endocrinology 114:1099-1107
65. Kogai T, Endo T, Saito T, Miyazaki A., Kawaguchi A, Onaya T 1997 Regulation by thyroid-stimulating hormone of sodium/iodide symporter gene expression and protein levels in FRTL-5 cells. Endocrinology 138:2227-2232
66. Behr M., Schmitt TL, Espinoza CR, Loos U 1998 Cloning of a functional promoter of the human sodium/iodide symporter gene. Biochem J 331:359-363
67. - symporter. J Clin Endocrinol Metab 83:3247-3251
68. Venkataraman MG, Yatin M, Ain KB 1998 Cloning of the human sodium-iodide symporter promoter and characterization in a differentiated human thyroid cell line, KAT-50. Thyroid 8:63-69
69. - symporter gene. Biochem Biophys Res Commun 239:34-41
70. - symporter gene. Mol Endocrinol 11:1747-1755
71. - symporter gene expression. Mol Endocrinol 12:727-736
72. Ohno M, Zannini M, Levy O, Carrasco N, Di Lauro R 1999 The paired-domain transcription factor Pax8 binds to the upstream enhancer of the rat sodium/iodide symporter gene and participates in both thyroid-specific and cyclic-AMP-dependent transcription. Mol Cell Biol 19:2051-2060
73. Schmutzler C, Schmitt TL, Glaser F, Loos U, Kohrle J 2002 The promoter of the human sodium/iodide-symporter gene responds to retinoic acid. Mol Cell Endocrinol 189:145-155
74. Schmutzler C 2001 Regulation of the sodium/iodide symporter by retinoids-a review. Exp Clin Endocrinol Diabetes 109:41-44
75. Garcia B, Santisteban P 2002 PI3K is involved in the IGF-I inhibition of TSH-induced sodium/iodide symporter gene expression. Mol Endocrinol 16:342-352
76. Vassart G, Dumont JE 1992 The thyrotropin receptor and the regulation of thyrocyte function and growth. Endocr Rev 13:596-611
77. Laglia G, Zeiger MA, Leipricht A, Caturegli P, Levine MA, Kohn LD, Saji M 1996 Increased cyclic adenosine 3′,5′-monophosphate inhibits G protein-coupled activation of phospholipase C in rat FRTL-5 thyroid cells. Endocrinology 137:3170-3176
78. - symporter mRNAs in dog thyroid. Mol Cell Endocrinol 131:195-203
79. Martino E, Bartalena L, Pinchera A 2000 Central hypothyroidism. In: Braverman LE, Utiger R, eds. The thyroid: a fundamental and clinical text. 8th ed. Philadelphia: Lippincott; 762-773
80. Kogai T, Curcio F, Hyman S, Cornford EM, Brent GA, Hershman JM 2000 Induction of follicle formation in long-term cultured normal human thyroid cells treated with thyrotropin stimulates iodide uptake but not sodium/iodide symporter messenger RNA and protein expression. J Endocrinol 167:125-135
81. - symporter in cultured human thyroid cells exposed to thyrotropin and in Graves' thyroid tissue. J Clin Endocrinol Metab 82:3331-3336
82. Marcocci C, Cohen JL, Grollman EF 1984 Effect of actinomycin D on iodide transport in FRTL-5 thyroid cells. Endocrinology 115:2123-2132
83. Riedel C, Levy O, Carrasco N 2001 Post-transcriptional regulation of the sodium/iodide symporter by thyrotropin. J Biol Chem 276:21458-21463
84. --transporting cultured thyroid cells. Proc Natl Acad Sci USA 91:3789-3793
85. Fanning AS, Anderson JM 1999 PDZ domains: fundamental building blocks in the organization of protein complexes at the plasma membrane. J Clin Invest 103:767-772
86. Tan PK, Waites C, Liu Y, Krantz DE, Edwards RH 1998 A leucine-based motif mediates the endocytosis of vesicular monoamine and acetylcholine transporters. J Biol Chem 273:17351-17360
87. Piguet V, Gu F, Foti M, Demaurex N, Gruenberg J, Carpentier JL, Trono D 1999 Nef-induced CD4 degradation: a diacidic-based motif in Nef functions as a lysosomal targeting signal through the binding of β-COP in endosomes. Cell 97:63-73
88. Perego C, Vanoni C, Villa A, Longhi R, Kaech SM, Frohli E, Hajnal A, Kim SK, Pietrini G 1999 PDZ-mediated interactions retain the epithelial GABA transporter on the basolateral surface of polarized epithelial cells. EMBO J 18:2384-2393
89. Dietrich J, Kastrup J, Nielsen BL, Odum N, Geisler C 1997 Regulation and function of the CD3 γ DxxxLL motif: a binding site for adaptor protein-1 and adaptor protein-2 in vitro. J Cell Biol 138:271-281
90. Marks MS, Ohno H, Kirchhausen T, Bonifacino JS 1997 Protein sorting by tyrosine-based signals: adapting to the Ys and wherefores. Trends Cell Biol 7:124-128
91. Voorhees P, Deignan E, Van Donselaar E, Humphrey J, Marks MS, Peters PJ, Bonifacino JS 1995 An acidic sequence within the cytoplasmic domain of furin functions as a determinant of trans-Golgi network localization and internalization from the cell surface. EMBO J 14:4961-4975
92. Waites CL, Mehta A, Tan PK, Thomas G, Edwards RH, Krantz DE 2001 An acidic motif retains vesicular monoamine transporter 2 on large dense core vesicles. J Cell Biol 152:1159-1168
93. Saito T, Endo T, Kawaguchi A, Ikeda M, Katoh R, Kawaoi A, Muramatsu A, Onaya T 1998 Increased expression of the sodium/iodide symporter in papillary thyroid carcinomas. J Clin Invest 101:1296-1300
94. - symporter (NIS) in a large sampling of thyroid cancer cases. J Clin Endocrinol Metab 86:2697-2700
95. Ramamoorthy S, Blakely RD 1999 Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. Science 285:763-766
96. Law RM, Stafford A, Quick MQ 2000 Functional regulation of γ-aminobutyric acid transporters by direct tyrosine phosphorylation. J Biol Chem 275:23986-23991
97. Krantz DE, Peter D, Liu Y, Edwards RH 1997 Phosphorylation of a vesicular monoamine transporter by casein kinase II. J Biol Chem 272:6752-6759
98. Krantz DE, Waites C, Oorschot V, Liu Y, Wilson RI, Tan PK, Klumperman J, Edwards RH 2000 A phosphorylation site regulates sorting of the vesicular acetylcholine transporter to dense core vesicles. J Cell Biol 149:379-396
99. Mehrens T, Lelleck S, Cetinkaya I, Knollmann M, Hohage H, Gorboulev V, Boknik P, Koepsell H, Schlatter E 2000 The affinity of the organic cation transporter rOCT1 is increased by protein kinase C-dependent phosphorylation. J Am Soc Nephrol 11:1216-1224
100. Glavy JS, Wu SM, Wang PJ, Orr GA, Wolkoff AW 2000 Down-regulation by extracellular ATP of rat hepatocyte organic anion transport is mediated by serine phosphorylation of oatp1. J Biol Chem 275:1479-1484
101. Riedel C, De la Vieja A, Ginter CS, Levy O, Carrasco N, TSH regulation of the thyroid iodide transporter (NIS). 2nd American Association of Pharmaceutical Scientists Frontier Symposium: Membrane Transporters and Drug Therapy, Bethesda, MD, 1999 (Abstract 41)
102. Plummer HS 1923 Results of administering iodine to patients having exophthalmic goiter. JAMA 80:1955
103. Morton ME, Chaikoff IL, Rosenfeld S 1944 Inhibiting effect of inorganic iodide on the formation in vitro of thyroxine and diiodotyrosine by surviving thyroid tissue. J Biol Chem 154:381-387
104. Wolff J, Chaikoff IL 1948 Plasma inorganic iodide as a homeostatic regulator of thyroid function. J Biol Chem 174:555-564
105. Raben MS 1949 the paradoxical effect of thiocyanate and of thyrotropin on the organic binding of iodine by the thyroid in the presence of large amounts of iodide. Endocrinology 45:296-304
106. Grollman EF, Smolar A, Ommaya A, Tombaccini D, Santisteban P 1986 Iodine suppression of iodide uptake in FRTL-5 thyroid cells. Endocrinology 118:2477-2482
107. Dugrillon A 1996 Iodolactones and iodoaldehydes -mediators of iodine in thyroid autoregulation. Exp Clin Endocrinol Diabetes 104:41-45
108. Panneels V, Van Sande J, Van den Bergen H, Jacoby C, Braekman JC, Dumont JE, Boeynaems JM 1994 Inhibition of human thyroid adenylyl cyclase by 2-iodoaldehydes. Mol Cell Endocrinol 106:41-50
109. 2 production by iodoaldehydes in cultured dog thyroid cells. Mol Cell Endocrinol 102:167-176
110. Wolff J, Chaikoff IL, Goldberg RC, Meier JC 1949 The temporary nature of the inhibitory action of excess iodide on organic iodide synthesis in the normal thyroid. Endocrinology 45:504
111. Braverman LE, Ingbar SH 1963 Changes in thyroidal function during adaptation to large doses of iodide. J Clin Invest 42:1216-1231
112. Spitzweg C, Joba W, Morris JC, Heufelder AE 1999 Regulation of sodium iodide symporter gene expression in FRTL-5 rat thyroid cells. Thyroid 9:821-830
113. Eng PHK, Cardona GR, Fang SL, Previti M, Alex S, Carrasco N, Chin WW, Braverman LE 1999 Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein. Endocrinology 140:3404-3410
114. Eng PHK, Cardona GR, Previti MC, Chin WW, Braverman LE 2001 Regulation of the sodium iodide symporter by iodide in FRTL-5 cells. Eur J Endocrinol 144:139-144
115. Nilsson M, Lindencrona U, Himmelman J, Sorensson P, Forsell-Aronsson E, Berg G, Jansson S, Nystrom E, Radiation-induced stunning of iodide accumulation is caused by specific inhibition of iodide transport. 12th International Thyroid Congress, Kyoto, Japan, 2000, p 185 (Abstract O-317)
116. Ajjan RA, Watson PF, Findlay C, Metcalfe RA, Crisp M, Ludgate M, Weetman AP 1998 The sodium iodide symporter gene and its regulation by cytokines found in autoimmunity. J Endocrinol 158:351-358
117. - symporter messenger ribonucleic acid levels in FRTL-5 cells. Endocrinology 139:703-712
118. +ATPase in FRTL-5 rat thyroid cells. J Interferon Cytokine Res 4:185-195
119. Rasmussen AK, Kayser L, Feldt-Rasmussen U 1994 Influence of tumor necrosis factor-α, tumor necrosis factor-β and interferon-γ, separately and added together with interleukin-1β, on the function of cultured human thyroid cells. J Endocrinol 143:359-365
120. Caturegli P, Hejazi M, Suzuki K, Dohan O, Carrasco N, Kohn LD, Rose NR 2000 Hypothyroidism in transgenic mice expressing IFN-γ in the thyroid. Proc Natl Acad Sci USA 97:1719-1724
121. Suzuki K, Lavaroni S, Mori A, Ohta M, Saito J, Pietrarelli M, Singer DS, Kimura S, Katoh R, Kawaoi A, Kohn LD 1998 Auto-regulation of thyroid-specific gene transcription by thyroglobulin. Proc Natl Acad Sci USA 95:8251-8256
122. Palumbo G, Tecce MF 1984 Molecular organization of 19 S calf thyroglobulin. Arch Biochem Biophys 233:169-173
123. Suzuki K, Mori A, Saito J, Moriyama E, Ullianich L, Kohn LD 1999 Follicular thyroglobulin suppresses iodide uptake by suppressing expression of the sodium/iodide symporter gene. Endocrinology 140:5422-5430
124. Kohn LD, Suzuki K, Nakazato M, Royaux I, Green ED 2001 Effects of thyroglobulin and pendrin on iodide flux through the thyrocyte. Trends Endocrinol Metab 12:10-16
125. Ulianich L, Suzuki K, Mori A, Nakazato M, Pietrarelli M, Goldsmith P, Pacifico F, Consiglio E, Formisano S, Kohn LD 1999 Follicular thyroglobulin (TG) suppression of thyroid-restricted genes involves the apical membrane asialoglycoprotein receptor and TG phosphorylation. J Biol Chem 274:25099-25107
126. Furlanetto TW, Nguyen LQ, Jameson JL 1999 Estradiol increases proliferation and down-regulates the sodium/iodide symporter gene in FRTL-5 cells. Endocrinology 140:5705-5711
127. Furlanetto TW, Nunes Jr RB, Sopelsa AM, Maciel RM 2001 Estradiol decreases iodide uptake by rat thyroid follicular FRTL-5 cells. Braz J Med Biol Res 34:259-263
128. Dremier S, Pohl V, Smith CP, Roger PP, Corbin J, Doskeland SO, Dumont JE, Maenhaur C 1997 Activation of cyclic AMP-dependent kinase is required but may not be sufficient to mimic cyclic AMP-dependent DNA synthesis and thyroglobulin expression in dog thyroid cells. Mol Cell Biol 17:6717-6726
129. Armstrong R, Wen W, Meinkoth J, Taylor S, Montiminy M 1995 A refractory phase in cyclic AMP-responsive transcription requires down regulation of protein kinase A. Mol Cell Biol 15:1826-1832
130. Ikuyama S, Shimura H, Hoeffler JP, Kohn LD 1992 Role of the cyclic adenosine 3′,5′-monophosphate response element in efficient expression of the rat thyrotropin receptor promoter. Mol Endocrinol 6:1701-1715
131. Damante G, Rapoport B 1998 TSH stimulates the activity of the c-fos promoter in FRTL-5 rat thyroid cells. Mol Cell Endocrinol 58:279-282
132. Damante G, Di Lauro R 1994 Thyroid-specific gene expression. Biochim Biophys Acta 1218:255-266
133. Dumont JE, Lamy F, Roger P, Maenhaut C 1992 Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol Rev 72:667-697
134. Kimura T, Van Keymeulen A, Golstein J, Fusco A, Dumont JE, Roger PP 2001 Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models. Endocr Rev 22:631-656
135. Gonzalez GA, Montiminy R 1989 Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 59:675-680
136. Medina DL, Santisteban P 2000 Thyrotropin-dependent proliferation of in vitro rat thyroid systems. Eur J Endocrinol 143:161-178
137. Pomerance M, Abdullah HB, Kamerji S, Correze C, Blondeau JP 2000 Thyroid-stimulating hormone and cyclic AMP activate p38 mitogen-activated protein kinase cascade. J Biol Chem 25:40539-40548
138. Cass LA, Summers SA, Prendergast GV, Backer JM, Birnbaum MJ, Meinkoth JL 1999 Protein kinase A-dependent and -independent signaling pathways contribute to cyclic AMP-stimulated proliferation. Mol Cell Biol 19:5882-5891
139. Cass LA, Meinkoth JL 1998 Differential effects of cyclic adenosine 3′,5′-monophosphate on p70 ribosomal S6 kinase. Endocrinology 139:1991-1998
140. Cass LA, Meinkoth JL 2000 Ras signaling through PI3K confers hormone-independent proliferation that is compatible with differentiation. Oncogene 19:924-932
141. Tsygankova OM, Kupperman E, Wen W, Meinkoth JL 2000 Cyclic AMP activates Ras. Oncogene 19:3609-3615
142. Al-Alawi N, Rose DW, Buckmaster C, Ahn N, Rapp U, Meinkoth J, Faramisco JR 1995 Thyrotropin-induced mitogenesis is Ras dependent but appears to bypass the Raf-dependent cytoplasmic kinase cascade. Mol Cell Biol 15:1162-1168
143. Kupperman E, Wen W, Meinkoth JL 1993 Inhibition of thyrotropin-stimulated DNA synthesis by microinjection of inhibitors of cellular Ras and cyclic AMP-dependent protein kinase. Mol Cell Biol 13:4477-4484
144. Ciullo I, Diez-Roux G, Di Domenico M, Migiaccio A, Avvedimento EV 192 2001 cAMP signaling selectively influences Ras effector pathways. Oncogene 20:1185-1181
145. Keymeulen A, Roger PP, Dumont JE, Dremier S 2000 TSH and cAMP do not signal mitogenesis through Ras activation. Biochem Biophys Res Commun 273:154-158
146. Burgering BMT, Box JL 1995 Regulation of Ras-mediated signalling: more than one way to skin a cat. Trends Biochem Sci 20:18-22
147. Wynford-Thomas D 1997 Origin and progression of thyroid epithelial tumors: cellular and molecular mechanisms. Horm Res 47:145-157
148. Dremier S, Vandeput F, Zwartkruis JT, Box JL, Dumont JE, Maenhaut C 2000 Activation of the small G protein Rap1 in dog thyroid cells by both cAMP-dependent and -independent pathways. Biochem Biophys Res Commun 267:7-11
149. Tsygankova OM, Saavedra A, Rebhun JF, Quilliam LA, Meinkoth JL 2001 Coordinated regulation of Rap1 and thyroid differentiation by cyclic AMP and protein kinase A. Mol Cell Biol 21:1921-1929
150. Richards JS 2001 New signaling pathways for hormones and cyclic adenosine 3′,5′-monophosphate action in endocrine cells. Mol Endocrinol 15:209-218
151. De Rooij J, Zwartkruis FJT, Verheijen MHG, Cools RH, Nijman SMB, Wittinghofer A, Bos JL 1998 Epac is a Rap1 guanine nucleotide-exchange factor directly activated by cAMP. Nature 396:474-477
152. Kawasaki H, Springett GM, Mochizuki N, Toki S, Nakaya M, Matsuda M, Housman DE, Graybiel AM 1998 A family of cAMP-binding proteins that directly activates Rap1. Science 282:2275-2279
153. Brown-Grant K 1961 Extra thyroidal iodide concentrating mechanisms. Physiol Rev 41:189-213
154. Ajjan RA, Kamaruddin NA, Crisp M, Watson PF, Ludgate M, Weetman AP 1998 Regulation and tissue distribution of the human sodium iodide symporter gene Clin Endocrinol (Oxf) 49:517-523
155. Spitzweg, C, Joba W, Eisenmenger W, Heufelder AE 1998 Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary DNA form salivary gland, mammary gland, and gastric mucosa. J Clin Endocrinol Metab 83:1746-1751
156. - symporter expression in mammary glands. J Clin Endocrinol Metab 85:2936-2943
157. - symporter distribution in human thyroid tissues: an immunohistochemical study. J Clin Endocrinol Metab 83:4102-4106
158. - symporter in human thyroid tissues and salivary gland tissues. Endocrinology 139:4416-4419
159. - symporter distribution in human extra-thyroid tissues. Eur J Endocrinol 141:382-386
160. Spitzweg C, Joba W, Schriever K, Goellner JR, Morris JC, Heufelder AE 1999 Analysis of human sodium iodide symporter immunoreactivity in human exocrine glands. J Clin Endocrinol Metab 84:4178-4184
161. Spitzweg C, Dutton CM, Castro MR, Bergert ER, Goellner JR, Heufelder AE, Morris JC 2001 Expression of the sodium iodide symporter in human kidney. Kidney Int 59:1013-1023
162. - symporter and pendred syndrome genes in trophoblast cells. J Clin Endocrinol Metab 85:4367-4372
163. Mitchell AM, Mandley SW, Morris JC, Powell KA, Bergert ER, Mortimer RH 2001 Sodium iodide symporter (NIS) gene expression in human placenta. Placenta 22:256-258
164. - symporter and pendred syndrome gene and protein expressions in human extra-thyroidal tissues. Eur J Endocrinol 144:297-302
165. Spitzweg C, Joba W, Heufelder AE 1999 Expression of thyroid-related genes in human thymus. Thyroid 9:133-141
166. Foley KP, Leonard, MW, Engel JD 1993 Quantification of RNA using the polymerase chain reaction. Trends Genet 9:380:385
167. Rillema JA, Yu TX, Jhiang SM 2000 Effect of prolactin on sodium iodide symporter expression in mouse mammary gland explants. Am J Physiol Endocrinol Metab 279:E769-E772
168. Stanbury JB, Dumont JE 1983 Familial goiter and related disorders. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS, eds. The metabolic basis of inherited disease. New York: McGraw-Hill; 231-269
169. Wolff J 1985 Congenital goiter with defective iodide transport. Endocr Rev 4:240-254
170. Toublanc J 1992 Comparison of epidemiological data on congenital hypothyroidism in Europe with those of other parts of the world. Horm Res 38:230-235
171. Abramowicz MJ, Targonik HM, Varela V, Cochaux P, Krawiec L, Pisarev MA 1992 Identification of a mutation in the coding sequence of the human thyroid peroxidase gene causing congenital goiter. J Clin Invest 90:1200-1204
172. Bikker H, Vulsma T, Baas F, de Vijlder JJM 1995 Identification of five novel inactivating mutations in the human thyroid peroxidase gene by denaturing gradient gel electrophoresis. Hum Mutat 6:9-16
173. Leiri T, Cochaux P, Targovnik HM, Suzuki M, Shimoda SI, Perret J 1991 A 3′ splice site mutation in the thyroglobulin gene responsible for congenital goiter with hypothyroidism. J Clin Invest 88:1901-1905
174. Medeiros-Neto G, Targovnik HM, Vassart G 1992 Defective thyroglobulin synthesis and secretion causing goiter and hypothyroidism. Endocr Rev 14:165-183
175. Abramowicz MJ, Duprez L, Parm J, Vassart G, Heinrichs C 1997 Familial congenital hypothyroidism due to inactivating mutation of the thyrotropin receptor causing profound hypoplasia of the thyroid gland. J Clin Invest 99:3018-3024
176. Sunthornthepvarukui, T, Gottschalk ME, Hayashi Y, Refetoff S 1995 Brief report: resistance to thyrotropin caused by mutations in the thyrotropin receptor gene. N Engl J Med 332:155-160
177. Federman D, Robbins J, Rall JE 1958 Some observations on cretinism and its treatment. N Engl J Med 259:610-616
178. Stanbury JB, Chapman EM 1960 Congenital hypothyroidism with goiter: absence of and iodide-contrasting mechanism. Lancet 1:1162-1165
179. Gilboa Y, Ber A, Lewitus Z, Hasenfratz J 1963 Goitrous myxedema due to iodide transport defect. Arch Intern Med 112:212-215
180. Wolff J, Thompson RH, Robbins J 1964 Congenital goitrous cretinism due to the absence of iodide-concentrating ability. J Clin Endocrinol Metab 24:699-707
181. Papadopoulos SN, Vagenakis AG, Moschos A, Koutras DA, Matsaniotis N, Malomos B, Bismuth J, Bechet HM, Lissitzky S 1970 A case of a partial defect of the iodide trapping mechanism. J Clin Endocrinol Metab 30:302-307
182. Medeiros-Neto GA, Bloise W, Ulhoa-Cintra AB 1972 Partial defect of iodide trapping mechanism in two siblings with congenital goiter and hypothyroidism. J Clin Endocrinol Metab 35:370-377
183. Hamada S, Kimura S, Yawata M 1974 A case of iodide concentration disorder thyroid disease accompanied by citrullinemia. Nippon Rinsho 32:2439-2442
184. Matsura M, Nishihata N, Kondo M, Zensak N, Suwa S 1975 An infant case of goitrous hypothyroidism due to iodide concentration disorders. Clin Endocrinol (Tokyo) 23:2383-2388
185. Savoie JC, Leger FA, Doumith R, Courpotin C 1977 Complete lack of active transport of iodide in congenital hypothyroidism, two unrelated cases. Ann Endocrinol (Paris) 38:16A (Abstract 28)
186. Toyoshima K, Masumoto Y, Nishida M, Yabuuchi H 1977 Five cases of absence of iodide concentrating mechanism. Acta Endocrinol (Copenh) 84:527-537
187. Pannall PR, Steyn AF, Van Reenen O 1978 Iodide-trapping defect of the thyroid. S Afr Med J 53:414-416
188. Dallot C, Labrune B, Courpotin C, Leger A, Grenet P 1980 Hypothyroidie par trouble congenital de la captation des iodures. Arch Fr Pediatr 37:597-601
189. Saito K, Yamamoto K, Yoshida S, Manabe S, Suzuki M, Takai T, Saito T, Kuzuya T, Moriyama S 1981 Goitrous hypothyroidism due to iodide-trapping defect. J Clin Endocrinol Metab 53:1267-1272
190. Couch RM, Dean HJ, Winter JSD 1985 Congenital hypothyroidism caused by defective iodide transport. J Pediatr 106:950-953
191. Miki K, Nose O, Tajiri H 1987 A case of congenital hypothyroidism due to iodide trapping defect with normal thyroid function transiently in the neonatal period. Clin Endocrinol (Tokyo) 37:945-948
192. Leger FA, Doumith R, Courpotin C, Helal OB, Davous N, Aurengo A, Savoie JC 1987 Complete iodide trapping defect in two cases with congenital hypothyroidism: adaptation of thyroid to huge iodide supplementation. Eur J Endocrinol 17:249-255
193. Albero R, Cerdan A, Sanchez-Franco F 1987 Congenital hypothyroidism form complete iodide transport defect: long-term evolution with iodide treatment. Postgrad Med J 63:1043-1047
194. Inomata H, Tamaru K, Sato H, Sasaki N, Niimi H, Nakajima H 1988 Two siblings of absence of iodide-concentrating mechanism. Nippon Shonika Gakkai Zaqsshi 92:2383-2388
195. Vulsma T, Rammeloo JA, Gons MH, De Vijlder JJM 1991 The role of serum thyroglobulin concentration and thyroid ultrasound imaging in the detection of iodide transport defect in infants. Acta Endocrinol (Copenh) 124:405-410
196. Matsuda A, Kosugi S 1997 A homozygous missense mutation of the sodium/iodide symporter gene causing iodide transport defect. J Clin Endocrinol Metab 82:3966-3971
197. - symporter in patients with iodide transport defect. J Clin Endocrinol Metab 83:2940-2943
198. Kosugi S, Sato Y, Matsuda A, Ohyama Y, Fujieda K, Inomata H, Kameya T, Isozaki O, Jhiang S 1998 High prevalence of T354P sodium/iodide symporter gene mutation in japanese patients with iodide transport defect who have heterogeneous clinical pictures. J Clin Endocrinol Metab 83:4123-4129
199. Kosugi S, Inoue S, Matsuda A, Jhiang SM 1998 Novel, missense and loss-of-function mutations in the sodium/iodide symporter gene causing iodide transport defect in three Japanese patients. J Clin Endocrinol Metab 83:3373-3376
200. Pohlenz J, Medeiros-Neto G, Gross JL, Silveiro SP, Knobel M, Refetoff S 1997 Hypothyroidism in a Brazilian kindred due to iodide trapping defect caused by a homozygous mutation in the sodium/iodide symporter gene. Biochem Biophys Res Commun 240:488-491
201. Pohlenz J, Rosenthal IM, Weiss RE, Jhiang SM, Burant C, Refetoff S 1998 Congenital hypothyroidism due to mutations in the sodium/iodide symporter. Identification of a nonsense mutation producing a downstream cryptic 3′ splice site. J Clin Invest 101:1028-1035
202. Camargo RYA, Gross JL, Silveiro SP, Knobel M, Medeiros-Neto G 1998 Pathological findings in dyshormonogenetic goiter with defective iodide transport. Endocr Pathol 9:225-233
203. Fujiwara H, Tatsumi K, Tanaka S, Kimura M, Nose O, Amino N 2000 A novel V59E missense mutation in the sodium iodide symporter gene in a family with iodide transport defect. Thyroid 10:471-474
204. Pohlez J, Duprez L, Weiss RE, Vassart G, Refetoff S, Costagliola S 2000 Failure of membrane targeting causes the functional defect of two mutant sodium iodide symporters. J Clin Endocrinol Metab 85:2366-2369
205. Kosugi S, Bhayana S, Dean HJ 1999 A novel mutation in the sodium/iodide symporter gene in the largest family with iodide transport defect. J Clin Endocrinol Metab 84:3248-3253
206. Skach WR 2000 Defects in processing and trafficking of the cystic fibrosis transmembrane conductance regulator. Kidney Int 57:825-831
207. +/glucose cotransporter (SGLT1) trafficking and function cause glucose-galactose malabsorption. Nat Genet 12:216-220
208. - cotransporter as a potential autoantigen in thyroid autoimmune disease. Eur J Endocrinol 132:399-405
209. - symporter in the sera of patients with autoimmune thyroid disease. Biochem Biophys Res Commun 224:92-95
210. Endo T, Kaneshige M, Nakazato M, Kogai T, Saito T, Onaya T 1996 Autoantibody against thyroid iodide transporter in the sera from patients with Hashimoto's thyroiditis possesses iodide transport inhibitory activity. Biochem Biophys Res Commun 228:199-120
211. Morris JC, Bergert ER, Bryant WP 1997 Binding of immunoglobulin G from patients with autoimmune thyroid disease to rat sodium-iodide symporter peptides: evidence for the iodide transporter as an autoantigen. Thyroid 4:527-534
212. Ajjan RA, Findlay C, Metcalfe RA, Watson PF, Crisp M, Ludgate M, Weetman AP 1998 The modulation of the human sodium iodide symporter activity by Graves sera. J Clin Endocrinol Metab 83:1217-1221
213. Ajjan RA, Kemp EH, Waterman EA, Watson, PF, Endo T, Onaya T, Weetman AP 2000 A detection of binding and blocking autoantibodies to the human sodium- iodide symporter in patients with autoimmune thyroid disease. J Clin Endocrinol Metab 85:2020-2027
214. - symporter (NIS) antibody with iodide uptake inhibiting activity in autoimmune thyroid diseases (AITD). J Clin Endocrinol Metab 85:3937-3940
215. Tonacchera M, Agretti P, Ceccarini G, Lenza R, Refetoff S, Santini F, Pinchera A, Chiovato L, Vitti P 2001 Autoantibodies from patients with autoimmune thyroid disease do not interfere with the activity of the human iodide symporter gene stably transfected in CHO cells. Eur J Endocrinol 144:611-618
216. - symporter in patients with autoimmune thyroid disease. J Clin Endocrinol Metab 85:4630-4634
217. Kemp EH, Waterman EA, Ajjan RA, Smith KA, Watson PF, Ludgate ME, Weetman AP 2001 Identification of antigenic domains on the human sodium-iodide symporter which are recognized by autoantibodies from patients with autoimmune thyroid disease. Clin Exp Immunol 124:377-385
218. Schneider AB, Ron E 2000 Carcinoma of follicular epithelium. In: Braverman LE, Utiger R, eds. The thyroid: a fundamental and clinical text. 8th ed. Philadelphia: Lippincott-Raven; 875-886
219. Mazzaferri EL, Kloos RT 2001 Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86:1447-1463
220. Schlumberger MJ 1998 Papillary and follicular thyroid carcinoma. N Engl J Med 338:297-306
221. Russo D, Manole D, Arturi F, Suarez HG, Schlumberger M, Filetti S, Derwahl M 2001 Absence of sodium/iodide symporter gene mutations in differentiated human thyroid carcinomas. Thyroid 11:37-39
222. Ryu KY, Senokozlieff ME, Smanik PA, Wong MG, Siperstein AE, Duh QY, Clark OH, Mazzaferri EL, Jhiang SM 1999 Development of reverse transcription-competitive polymerase chain reaction method to quantitate the expression levels of human sodium iodide symporter. Thyroid 9:405-409
223. - symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes. J Clin Endocrinol Metab 84:3228-3234
224. Park HJ, Kim JY, Park KY, Gong G, Hong SJ Ahn IM 2000 Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas. Thyroid 10:211-217
225. Arturi F, Russo D, Schlumberger M, du Villard, JA, Caillou B, Vigneri P, Wicker R, Chiefari E, Suarez, HG, Filetti S 1998 Iodide symporter gene expression in human thyroid tumors. J Clin Endocrinol Metab 83:2493-2496
226. Tanaka K, Otsuki T, Sonoo H, Yamamoto, Yudagawa K, Kunisue H, Arime I, Yamamoto S, Kurebayashi J, Shimozuma K 2000 Semi-quantitative comparison of the differentiation markers and sodium iodide symporter messenger ribonucleic acids in papillary thyroid carcinomas using RT-PCR. Eur J Endocrinol 142:340-346
227. Arturi F, Russo D, Giuffrida D, Schlumberger M, Filetti S 2001 Sodium-iodide symporter (NIS) gene expression in lymph-node metastases of papillary thyroid carcinomas. Eur J Endocrinol 143:623-627
228. Castro MR, Bergert ER, Beito TG, Roche PC, Ziesmer SC, Jhiang SM, Goellner JR, Morris JC 1999 Monoclonal antibodies against the human sodium iodide symporter: utility for immunocytochemistry of thyroid cancer. J Endocrinol 163:495-504
229. Mizukami Y, Matsubara F, Matsukawa S 1983 Changes in localization of ouabain-sensitive, potassium-dependent p-nitrophenylphosphatase activity in human thyroid carcinoma cells. Lab Invest 48:411-418
230. Westermark K, Lundqvist M, Wallin G, Dahlman T, Hacker GW, Heldin NE, Grimelius L 1996 EGF-receptors in human normal and pathological thyroid tissue. Histopathology 28:221-227
231. Tonacchera M, Viacava P, Agretti P, de Marco G, Perri A, di Cosmo C, de Servi M, Miccoli P, Lippi F, Naccarato AG, Pinchera A, Chiovato L, Vitti P 2002 Benign nonfunctioning thyroid adenomas are characterized by a defective targeting to cell membrane or a reduced expression of the sodium iodide symporter protein. J Clin Endocrinol Metab 2002 87:352-357
232. - symporter gene methylation status J Clin Endocrinol Metab 84:2449-2457
233. Schmutzler C, Winzer R, Meissner-Weigl J, Kohrle J 1997 Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells. Biochem Biophys Res Commun 240:832-838
234. Kogai T, Hershman JM, Motomura K, Endo T, Onaya T, Brent GA 2001 Differential regulation of the human sodium/iodide symporter gene promoter in papillary thyroid carcinoma cell lines and normal thyroid cells. Endocrinology 142:3369-3379
235. Kogai T, Schultz JJ, Johnson LS, Huang M, Brent GA 2000 Retinoic acid induces sodium/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line. Proc Natl Acad Sci USA 97:8519-8524
236. Spitzweg C, Zhang S, Bergert ER, Castro MR, McIver B, Heufelder AE, Tindall DJ, Young CY, Morris JC 1999 Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines. Cancer Res 59:2136-2141
237. Spitzweg C, O'Connor MK, Bergert ER, Tindall DJ, Young CY, Morris JC 2000 Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter. Cancer Res 15:6526-6530
238. Spitzweg C, Dietz AB, O'Connor MK, Bergert ER, Tindall DJ, Young CY, Morris JC 2001 In vivo sodium iodide symporter gene therapy of prostate cancer. Gene Ther 8:1524-1531
239. Mazzaferri EL 1996 Carcinoma of follicular epithelium: radioiodine and other treatments and outcomes. In: Braverman LE, Utiger RD, eds. The thyroid: a fundamental and clinical text. 8th ed. Philadelphia: Lippincott-Raven; 904-929
240. Mazzaferri EL, Jhiang SM 1994 Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418-428
241. - symporter gene. Endocrinology 138:4493-4496
242. Mandell RB, Mandell LZ, Link Jr CJ 1999 Radioisotope concentrator gene therapy using the sodium/iodide symporter gene. Cancer Res 59:661-668
243. - symporter in human glioma cells by adenovirus-mediated gene delivery. Gene Ther 7:740-749
244. - transport system in plasma membrane vesicles from thyroid glands. Biochim Biophys Acta 896:263-274
245. Nakamura Y, Ohtaki S, Yamazaki I 1988 Molecular mechanism of iodide transport by thyroid plasmalemmal vesicles: cooperative sodium activation and asymmetrical affinities for the ions on the outside and inside of the vesicles. J Biochem (Tokyo) 104:544-549